↓ Skip to main content

Hepatic drug metabolizing profile of Flinders Sensitive Line rat model of depression

Overview of attention for article published in Progress in Neuro-Psychopharmacology & Biological Psychiatry, June 2010
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
18 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Hepatic drug metabolizing profile of Flinders Sensitive Line rat model of depression
Published in
Progress in Neuro-Psychopharmacology & Biological Psychiatry, June 2010
DOI 10.1016/j.pnpbp.2010.05.029
Pubmed ID
Authors

Olga Kotsovolou, Magnus Ingelman-Sundberg, Matti A. Lang, Marios Marselos, David H. Overstreet, Zoi Papadopoulou-Daifoti, Inger Johanson, Andrew Fotopoulos, Maria Konstandi

Abstract

The Flinders Sensitive Line (FSL) rat model of depression exhibits some behavioral, neurochemical, and pharmacological features that have been reported in depressed patients and has been very effective in screening antidepressants. Major factor that determines the effectiveness and toxicity of a drug is the drug metabolizing capacity of the liver. Therefore, in order to discriminate possible differentiation in the hepatic drug metabolism between FSL rats and Sprague-Dawley (SD) controls, their hepatic metabolic profile was investigated in this study. The data showed decreased glutathione (GSH) content and glutathione S-transferase (GST) activity and lower expression of certain major CYP enzymes, including the CYP2B1, CYP2C11 and CYP2D1 in FSL rats compared to SD controls. In contrast, p-nitrophenol hydroxylase (PNP), 7-ethoxyresorufin-O-dealkylase (EROD) and 16alpha-testosterone hydroxylase activities were higher in FSL rats. Interestingly, the wide spread environmental pollutant benzo(alpha)pyrene (B(alpha)P) induced CYP1A1, CYP1A2, CYP2B1/2 and ALDH3c at a lesser extend in FSL than in SD rats, whereas the antidepressant mirtazapine (MIRT) up-regulated CYP1A1/2, CYP2C11, CYP2D1, CYP2E1 and CYP3A1/2, mainly, in FSL rats. The drug also further increased ALDH3c whereas suppressed GSH content in B(alpha)P-exposed FSL rats. In conclusion, several key enzymes of the hepatic biotransformation machinery are differentially expressed in FSL than in SD rats, a condition that may influence the outcome of drug therapy. The MIRT-induced up-regulation of several drug-metabolizing enzymes indicates the critical role of antidepressant treatment that should be always taken into account in the designing of treatment and interpretation of insufficient pharmacotherapy or drug toxicity.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 6%
China 1 6%
Unknown 16 89%

Demographic breakdown

Readers by professional status Count As %
Student > Master 3 17%
Professor > Associate Professor 3 17%
Researcher 3 17%
Lecturer 2 11%
Student > Ph. D. Student 1 6%
Other 3 17%
Unknown 3 17%
Readers by discipline Count As %
Psychology 4 22%
Biochemistry, Genetics and Molecular Biology 3 17%
Agricultural and Biological Sciences 3 17%
Medicine and Dentistry 2 11%
Neuroscience 1 6%
Other 1 6%
Unknown 4 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 December 2014.
All research outputs
#22,759,452
of 25,374,647 outputs
Outputs from Progress in Neuro-Psychopharmacology & Biological Psychiatry
#2,398
of 2,706 outputs
Outputs of similar age
#100,264
of 105,068 outputs
Outputs of similar age from Progress in Neuro-Psychopharmacology & Biological Psychiatry
#26
of 26 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,706 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.0. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 105,068 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 26 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.